Cargando…

Real-world effectiveness and safety of adalimumab in Korean patients with intestinal Behcet’s disease: a Korean Association for the Study of Intestinal Diseases (KASID) multicenter study

BACKGROUND/AIMS: The short- and long-term effects of adalimumab (ADA) on Korean patients with intestinal Behcet’s disease (BD) for remain unclear. Therefore, a multicenter study was performed to evaluate the efficacy and safety of ADA in Korean patients with intestinal BD in a real-world setting. ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Seung Bum, Hong, Hee Seung, Lee, Chang Kyun, Lee, Bo-In, Kim, Sol, Koh, Seong-Joon, Yu, Hosun, Park, Jung-Bin, Hwang, Sung Wook, Ye, Byong Duk, Yang, Suk-Kyun, Park, Sang Hyoung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Association of Internal Medicine 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493451/ https://www.ncbi.nlm.nih.gov/pubmed/37491721 http://dx.doi.org/10.3904/kjim.2022.394

Ejemplares similares

Real-world effectiveness and safety of ustekinumab induction therapy for Korean patients with Crohn’s disease: a KASID prospective multicenter study
por: Oh, Kyunghwan, et al.
Publicado: (2023)

Use of Thiopurines in Inflammatory Bowel Disease: A Consensus Statement by the Korean Association for the Study of Intestinal Diseases (KASID)
por: Lee, Kang-Moon, et al.
Publicado: (2015)

Corrigendum: Real-world effectiveness and safety of ustekinumab induction therapy for Korean patients with Crohn’s disease: a KASID prospective multicenter study
por: Oh, Kyunghwan, et al.
Publicado: (2023)

Clinical and Genetic Characteristics of Korean Patients Diagnosed with Chronic Enteropathy Associated with SLCO2A1 Gene: A KASID Multicenter Study
por: Hong, Hee Seung, et al.
Publicado: (2022)

Clinical Course of COVID-19 in Patients with Inflammatory Bowel Disease in Korea: a KASID Multicenter Study
por: Lee, Jin Wook, et al.
Publicado: (2021)

Long-term Outcomes of Adalimumab Therapy in Korean Patients with Ulcerative Colitis: A Hospital-Based Cohort Study
por: Oh, Eun Hye, et al.
Publicado: (2020)

Three-year colonoscopy surveillance after polypectomy in Korea: a Korean Association for the Study of Intestinal Diseases (KASID) multicenter prospective study
por: Choi, Won Seok, et al.
Publicado: (2018)

Clinical and endoscopic characteristics of sessile serrated adenomas/polyps with dysplasia/adenocarcinoma in a Korean population: A Korean Association for the Study of Intestinal Diseases (KASID) multicenter study
por: Kim, Ki-Hyun, et al.
Publicado: (2019)

Seroprevalence of viral infectious diseases and associated factors in Korean patients with inflammatory bowel diseases
por: Hong, Hee Seung, et al.
Publicado: (2022)

Real-life effectiveness and safety of tofacitinib treatment in patients with ulcerative colitis: a KASID multicenter cohort study
por: Shin, Seung Hwan, et al.
Publicado: (2023)

Second Korean guidelines for the management of Crohn's disease
por: Park, Jae Jun, et al.
Publicado: (2017)

Infliximab versus Adalimumab: Can We Choose the Right One for the Right Patients with Ulcerative Colitis?
por: Park, Sang Hyoung, et al.
Publicado: (2022)

Insufficient vaccination and inadequate immunization rates among Korean patients with inflammatory bowel diseases
por: Ryu, Han Hee, et al.
Publicado: (2021)

Balloon-Assisted Enteroscopy for Retrieval of Small Intestinal Foreign Bodies: A KASID Multicenter Study
por: Kim, Jeongseok, et al.
Publicado: (2020)

Primary Sclerosing Cholangitis with Inflammatory Bowel Disease in Korean Children
por: Yoon, Jisun, et al.
Publicado: (2015)

Efficacy of Adalimumab in a Girl with Refractory Intestinal Behcet's Disease
por: Kaji, Mariko, et al.
Publicado: (2015)

Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy?
por: Park, Jihye, et al.
Publicado: (2017)

Oral beclomethasone dipropionate as an add-on therapy and response prediction in Korean patients with ulcerative colitis
por: Kim, Kyuwon, et al.
Publicado: (2022)

Identification of genetic susceptibility loci for intestinal Behçet’s disease
por: Kim, Seung Won, et al.
Publicado: (2017)

Temporal trends in the misdiagnosis rates between Crohn’s disease and intestinal tuberculosis
por: Seo, Hyungil, et al.
Publicado: (2017)

Efficacy of Adalimumab in Korean Patients with Crohn’s Disease
por: Sohn, Il Woong, et al.
Publicado: (2016)

Does the intestinal microbial community of Korean Crohn’s disease patients differ from that of western patients?
por: Eun, Chang Soo, et al.
Publicado: (2016)

Behçet's disease-induced massive small intestinal bleeding successfully treated with adalimumab
por: Liu, PH, et al.
Publicado: (2023)

Frequency of peripheral diseases in Korean patients with ankylosing spondylitis and the effectiveness of adalimumab
por: Lee, Sang‐Hoon, et al.
Publicado: (2020)

Clinical correlations of infliximab trough levels and antibodies to infliximab in South Korean patients with Crohn’s disease
por: Oh, Eun Hye, et al.
Publicado: (2017)

Changes in prevalence and perception of complementary and alternative medicine use in Korean inflammatory bowel disease patients: results of an 8-year follow-up survey
por: Lee, Sun-Ho, et al.
Publicado: (2020)

Long-Term Efficacy of Adalimumab in Patients With Intestinal Behcet’s Disease: Eight Consecutive Cases
por: Tanida, Satoshi, et al.
Publicado: (2016)

Renal Manifestations in 2007 Korean Patients with Behçet's Disease
por: Cho, Sung Bin, et al.
Publicado: (2013)

Expression Quantitative Trait Loci (eQTL) Mapping in Korean Patients With Crohn’s Disease and Identification of Potential Causal Genes Through Integration With Disease Associations
por: Jung, Seulgi, et al.
Publicado: (2020)

Impact of inflammatory bowel disease on daily life: an online survey by the Korean Association for the Study of Intestinal Diseases
por: Kim, Young Sun, et al.
Publicado: (2017)

Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study
por: Shin, Seung Yong, et al.
Publicado: (2022)

Adalimumab in the management of Behçet’s disease
por: Ueda, Atsuhisa, et al.
Publicado: (2015)

Usefulness of Adalimumab for Treating a Case of Intestinal Behçet's Disease With Trisomy 8 Myelodysplastic Syndrome
por: Kimura, Masamichi, et al.
Publicado: (2015)

Intercellular adhesion molecule-1 polymorphisms in Korean patients with Behcet s disease.
por: Kim, Eun Hee, et al.
Publicado: (2003)

Characteristic Phenotypes in Korean Crohn's Disease Patients Who Underwent Intestinal Surgery for the Treatment
por: Baik, Seung Hyuk, et al.
Publicado: (2013)

Outcome Predictors for Intestinal Behçet's Disease
por: Park, Jae Jun, et al.
Publicado: (2013)

SARS-CoV-2 vaccination for adult patients with inflammatory bowel disease: expert consensus statement by KASID
por: Lee, Yoo Jin, et al.
Publicado: (2022)

The Effect of Adalimumab in Korean Patients with Refractory Noninfectious Uveitis
por: Park, Sung Eun, et al.
Publicado: (2021)

A Novel Chronic Enteropathy Associated with SLCO2A1 Gene Mutation: Enterography Findings in a Multicenter Korean Registry
por: Jeong, Boryeong, et al.
Publicado: (2023)

Use of device-assisted enteroscopy in small bowel disease: an expert consensus statement by the Korean Association for the Study of Intestinal Diseases
por: Lee, Han Hee, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dfdbtr7o9ri7apt76qsl97ckos